Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate–High Risk: A Cost-Effectiveness Analysis

Total article views   HTML views PDF downloads Totals
5,014 Dovepress* 4,512+ 508 5,020
PubMed Central* 502 199 701
Totals 5,014 707 5,721
*Since 22 July 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar